Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research
10
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
10.0%
1 terminated/withdrawn out of 10 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Insufficient Oxygenation in Septic Patients
Role: lead
Mitochondrial Oxygen Measurement Variability in Critically Ill Patients (INOX Variability Study)
Role: lead
Bleeding In Thrombocytopenia Explained
Role: lead
Mortality After Transfusion of Ever-pregnant Donor Red Blood Cells
Role: lead
Insufficient Cellular Oxygen in ICU Patients With Anaemia
Role: lead
R-FACT Study:Risk Factors for Alloimmunization After Red Blood Cell Transfusions
Role: lead
Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia
Role: collaborator
EPO-4-Rhesus Study
Role: lead
Towards Better Prognostic and Diagnostic Strategies for Haemostatic Changes During Major Obstetric Haemorrhage
Role: lead
Monitoring Outcome in Neonatal Thrombocytopenia
Role: lead
All 10 trials loaded